Extendicare Inc.

TSX:EXE.TO

Medical - Care Facilities

Healthcare
$28.81 +2.61%

+$0.86 today

Market cap
$2.74B
Beta
1.16
P/E (TTM)
26.4
EPS (TTM)
$1.28
Dividend yield
1.51%
52W Low $12.12High $35.62

Volume 0.86M

Average 0.34M

EXE.TO Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

Extendicare Inc.TSX: EXE.TO

Operating Expenses · Q2 FY2026 · quarter ended Jun 2026

Operating expenses growth accelerates

Q2 FY2026 operating expenses of CA$558.81M rose 58.7% year over year, ahead of the -5.2% change in trailing-twelve-month operating expenses. Sequentially, it rose 3356.7% from the prior quarter. Over 3 fiscal years it compounded at +6.4% a year.

Context

  • Operating expenses amounted to 3.7% of revenue in FY2025, down 0.2 pp from a year earlier.
  • Operating expenses increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +58.7% holds above the trailing-twelve-month pace of -5.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
CA$558.81M+3356.7% QoQ
Last fiscal yearDec 2025
CA$61.22M+7.5% YoY
LTMJun 2026
CA$990.68M-5.2% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+58.7%——
1 year+7.5%——
3-year CAGR+6.4%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

CAD · from the income statement

Latest · FY2025
61.22M CAD
Year-over-year change
+7.5%
4-year CAGR
+4.0%

Operating Expenses vs competitors

How EXE.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -5.2% is the 4th highest of 7, against a peer median of -4.0%.
  • Operating expenses amounts to 50.1% of revenue for EXE.TO, versus a peer median of 32.2%.
EXE.TO Competitors
Operating Expenses for EXE.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TLRY.TOTilray Brands, Inc.LTM Feb 2026$1.72B USD+76.0%+127.0%200.3%
EXE.TOExtendicare Inc.LTM Jun 2026CA$990.68M CAD-5.2%+6.4%50.1%
WELL.TOWELL Health Technologies Corp.LTM Mar 2026CA$420.05M CAD+2.5%+13.8%28.5%
DR.TOMedical Facilities CorporationLTM Mar 2026$109.68M USD-23.5%-40.9%35.9%
CRRX.TOCareRx CorporationLTM Mar 2026CA$87.09M CAD-10.5%-0.6%23.2%
CRON.TOCronos Group Inc.LTM Mar 2026$79.67M USD-22.8%-14.7%50.0%
SIA.TOSienna Senior Living Inc.LTM Sep 2026CA$45.24M CAD+19.2%+9.5%4.1%
Peer median (excluding EXE.TO) —-4.0%+4.5%32.2%

Competitors are the stored peer set for EXE.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.17B1.22B1.3B1.47B1.66B
Cost of Revenue1.05B1.14B1.14B1.3B1.46B
Gross Profit115.61M76.83M167.62M168M199.59M
Gross Margin9.9%6.3%12.8%11.5%12.0%
Research & Development00000
Selling, General & Admin69.79M51.08M55.84M1.2B1.36B
Operating Expenses52.43M50.78M55.84M56.94M61.22M
Depreciation & Amortization38.57M32.12M32.23M33.34M37.25M
EBITDA75M49.33M98.63M155.27M175.61M
EBITDA Margin6.4%4.0%7.6%10.6%10.6%
Operating Income49.71M20.99M62.96M111.21M138.37M
Operating Margin4.3%1.7%4.8%7.6%8.3%
Interest Income1.87M5.02M6.19M7.04M5.73M
Interest Expense22.45M21.7M21.6M21.1M19.23M
Other Income / Expenses(35.72M)(25.48M)(18.16M)(11.35M)(8.26M)
Income Before Tax13.99M(4.5M)44.8M99.86M130.1M
Pre-Tax Margin1.2%-0.4%3.4%6.8%7.8%
Income Tax Expense6.48M15K10.82M24.65M33.45M
Net Income11.5M69.55M33.98M75.21M96.66M
Net Margin1.0%5.7%2.6%5.1%5.8%
EPS (Basic)0.130.850.400.971.13
EPS (Diluted)0.130.850.400.861.11
Weighted Avg Shares89.99M89.01M84.99M84.22M85.4M
Weighted Avg Shares (Diluted)100.9M89.01M84.99M95.36M86.84M

Extendicare Inc.

TSX:EXE.TO

Intrinsic Alpha fair value

Locked

Current Price

$28.81

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.